Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study.

Quimby AE, Lebo NL, Griffiths R, Hall S, Dimitroulakos J, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2018 Dec 4;47(1):74. doi: 10.1186/s40463-018-0322-7.

2.

C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer.

Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J.

Otolaryngol Head Neck Surg. 2018 Sep 18:194599818800297. doi: 10.1177/0194599818800297. [Epub ahead of print]

PMID:
30226795
3.

Does Socioeconomic Status Affect Stage at Presentation for Larynx Cancer in Canada's Universal Health Care System?

Khalil D, Corsten MJ, Holland M, Balram A, McDonald JT, Johnson-Obaseki S.

Otolaryngol Head Neck Surg. 2018 Sep 11:194599818798626. doi: 10.1177/0194599818798626. [Epub ahead of print]

PMID:
30200820
4.

Correction to: HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.

Wasserman JK, Rourke R, Purgina B, Caulley L, Dimitroulakos J, Corsten M, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2018 Aug 2;47(1):49. doi: 10.1186/s40463-018-0294-7.

5.

Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.

Lebo NL, Griffiths R, Hall S, Dimitroulakos J, Johnson-Obaseki S.

Head Neck. 2018 Aug;40(8):1697-1706. doi: 10.1002/hed.25152. Epub 2018 Jun 22.

PMID:
29934959
6.

Immediate versus delayed reconstruction of head and neck cutaneous melanoma.

Quimby AE, Khalil D, Johnson-Obaseki S.

Laryngoscope. 2018 Nov;128(11):2566-2572. doi: 10.1002/lary.27250. Epub 2018 Jun 22.

PMID:
29932227
7.

Customized Viral Immunotherapy for HPV-Associated Cancer.

Atherton MJ, Stephenson KB, Pol J, Wang F, Lefebvre C, Stojdl DF, Nikota JK, Dvorkin-Gheva A, Nguyen A, Chen L, Johnson-Obaseki S, Villeneuve PJ, Diallo JS, Dimitroulakos J, Wan Y, Lichty BD.

Cancer Immunol Res. 2017 Oct;5(10):847-859. doi: 10.1158/2326-6066.CIR-17-0102. Epub 2017 Sep 14.

8.

Peri-operative factors predisposing to pharyngocutaneous fistula after total laryngectomy: analysis of a large multi-institutional patient cohort.

Lebo NL, Caulley L, Alsaffar H, Corsten MJ, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2017 Aug 23;46(1):54. doi: 10.1186/s40463-017-0233-z.

9.

Primary Burkitt lymphoma of the supraglottic larynx: a case report and review of the literature.

Quimby AE, Caulley L, Rodin D, Purgina B, Eapen L, Shier L, Johnson-Obaseki S.

J Med Case Rep. 2017 Mar 10;11(1):65. doi: 10.1186/s13256-017-1209-3. Review.

10.

Nasopharyngeal non-intestinal-type adenocarcinoma: a case report and updated review of the literature.

Jain C, Caulley L, Macdonald KI, Purgina B, Lai CK, Esche B, Johnson-Obaseki S.

Curr Oncol. 2017 Feb;24(1):e55-e60. doi: 10.3747/co.24.3299. Epub 2017 Feb 27.

11.

Cost-Effectiveness Analysis of Radiation Therapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.

Rodin D, Caulley L, Burger E, Kim J, Johnson-Obaseki S, Palma D, Louie AV, Hansen A, O'Sullivan B.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):709-717. doi: 10.1016/j.ijrobp.2016.11.029. Epub 2016 Nov 27. Review.

PMID:
28244405
12.

Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program.

Caulley L, Johnson-Obaseki S, Luo L, Javidnia H.

Medicine (Baltimore). 2017 Feb;96(5):e5752. doi: 10.1097/MD.0000000000005752.

13.

HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.

Wasserman JK, Rourke R, Purgina B, Caulley L, Dimitroulakis J, Corsten M, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2017 Jan 6;46(1):3. doi: 10.1186/s40463-016-0179-6. Erratum in: J Otolaryngol Head Neck Surg. 2018 Aug 2;47(1):49.

14.

Complication rates of open surgical versus percutaneous tracheostomy in critically ill patients.

Johnson-Obaseki S, Veljkovic A, Javidnia H.

Laryngoscope. 2016 Nov;126(11):2459-2467. doi: 10.1002/lary.26019. Epub 2016 Apr 14. Review.

PMID:
27075530
15.

Is there a group of patients at greater risk for hematoma following thyroidectomy? A systematic review and meta-analysis.

Quimby AE, Wells ST, Hearn M, Javidnia H, Johnson-Obaseki S.

Laryngoscope. 2017 Jun;127(6):1483-1490. doi: 10.1002/lary.26195. Epub 2016 Aug 2. Review.

PMID:
27481173
16.

Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006.

Johnson-Obaseki SE, Labajian V, Corsten MJ, McDonald JT.

J Otolaryngol Head Neck Surg. 2015 Dec 2;44:53. doi: 10.1186/s40463-015-0107-1.

17.

Incidence of differentiated thyroid cancer in Canada by City of residence.

Corsten MJ, Hearn M, McDonald JT, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2015 Sep 15;44:36. doi: 10.1186/s40463-015-0088-0.

18.

Response to: "No evidence for improved TORS post-treatment feeding tube dependency rate relative to standard therapy in early stage oropharyngeal cancer".

Johnson-Obaseki S, Kelly K, Corsten M.

Oral Oncol. 2015 Sep;51(9):e68. doi: 10.1016/j.oraloncology.2015.06.001. Epub 2015 Jun 26. No abstract available.

PMID:
26120092
19.

Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors.

Dayekh K, Johnson-Obaseki S, Corsten M, Villeneuve PJ, Sekhon HS, Weberpals JI, Dimitroulakos J.

Mol Cancer Ther. 2014 Nov;13(11):2559-71. doi: 10.1158/1535-7163.MCT-13-1086. Epub 2014 Sep 4.

20.

Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review.

Kelly K, Johnson-Obaseki S, Lumingu J, Corsten M.

Oral Oncol. 2014 Aug;50(8):696-703. doi: 10.1016/j.oraloncology.2014.04.005. Epub 2014 Jun 7. Review.

PMID:
24917389
21.

The relationship between survival and socio-economic status for head and neck cancer in Canada.

McDonald JT, Johnson-Obaseki S, Hwang E, Connell C, Corsten M.

J Otolaryngol Head Neck Surg. 2014 Jan 14;43:2. doi: 10.1186/1916-0216-43-2.

22.

Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007.

Hwang E, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M.

Oral Oncol. 2013 Nov;49(11):1072-6. doi: 10.1016/j.oraloncology.2013.08.002. Epub 2013 Sep 7.

PMID:
24018186
23.

Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006.

Guay B, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M.

Thyroid. 2014 Mar;24(3):552-5. doi: 10.1089/thy.2013.0308. Epub 2013 Nov 14.

PMID:
24003960
24.

Head and neck cancer in Canada: trends 1992 to 2007.

Johnson-Obaseki S, McDonald JT, Corsten M, Rourke R.

Otolaryngol Head Neck Surg. 2012 Jul;147(1):74-8. doi: 10.1177/0194599812437332. Epub 2012 Feb 10.

PMID:
22328702

Supplemental Content

Loading ...
Support Center